论文部分内容阅读
河南爱尔康科技有限公司是2012年成立的一家公司,公司的主营业务为新生儿多种遗传代谢病筛查,该业务已开展一年时间,成效显著,公司2014年准备走混合多样化道路,在主营业务的基础上开展两种新业务——产前筛查与婴幼通业务,本文以一个实际市场参与者的视角通过对公司的优势、劣势分析和对公司的市场运营环境分析,试图对公司的混合多样化策略做出科学评判,以期为公司的长久可持续发展做一借鉴。
Henan Alcon Technology Co., Ltd. is a company set up in 2012, the company’s main business is a variety of neonatal screening for genetic and metabolic diseases, the business has been carried out for a year, the results are remarkable, the company plans to take in 2014 mixed diversification Road, on the basis of the main business to carry out two new business - prenatal screening and infant and young Tong business, this article from the perspective of an actual market participants through the company’s strengths and weaknesses analysis and the company’s market operating environment Analysis, try to make a scientific evaluation of the company’s diversification strategy, in order to make a reference for the company’s long-term sustainable development.